今日药学

2017, v.27(08) 551-554

[打印本页] [关闭]
本期目录(Current Issue) | 过刊浏览(Past Issue) | 高级检索(Advanced Search)

处方审核需关注——处方级联(Prescribing Cascade)
“Prescribing Cascade” Should be Given Sufficient Consideration During Prescription Review

伍俊妍;吴凯珊;郑志华;
WU Junyan;WU Kaishan;ZHENG Zhihua;Sun Yat-Sen Memorial Hospital,Sun Yat-Sen University;Guangdong Pharmaceutical Association;

摘要(Abstract):

处方级联是指处方给患者一种药物,引起了不良事件体征和症状,为处理这些不良事件体征和症状,从而导致新的药物处方的情况。这个新的药物处方又可引起新的不良事件体征和症状,从而产生下一个处方级联。处方级联的概念在1995年被国外学者提出并得到认同且被广泛研究;而在国内,处方级联尚未得到关注及重视。处方级联危害患者健康,应被关注及研究。
A prescribing cascade occurs when a new drug was prescribed to "treat "an adverse reaction of another drug. The definition of prescribing cascade was raised by the foreign scholars in 1995 initially,and had been widespread to be recognized and researched. However,prescribing cascade had not given enough attention in China. Prescribing cascade is harmful for patients,and need to be recognized and researched in China.

关键词(KeyWords): 处方级联;合理用药;处方精简
prescribing cascade;rational medication;deprescribing

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 伍俊妍;吴凯珊;郑志华;
WU Junyan;WU Kaishan;ZHENG Zhihua;Sun Yat-Sen Memorial Hospital,Sun Yat-Sen University;Guangdong Pharmaceutical Association;

Email:

DOI:

参考文献(References):

扩展功能
本文信息
服务与反馈
本文关键词相关文章
本文作者相关文章
中国知网
分享